Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Supervisor), Dogné, J.-M. (Co-supervisor), Favresse, J. (CoI), Tre-Hardy, M. (CoI), Mullier, F. (CoI), Haguet, H. (Researcher), Hardy, M. (Researcher), Melchionda, S. (Researcher), BOUVY, C. (Researcher), Morimont, L. (Researcher), Gillot, C. (Researcher), Djokoto, H. (Researcher), Alpan, L. (Technician), Devel, P. (Technician), Modaffari, E. (Technician) & Maloteau, V. (Technician)
13/03/20 → …
Project: Research
-
The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J. (Supervisor), Mullier, F. (Co-supervisor), Haguet, H. (Researcher) & RONVAUX, L. (Researcher)
1/09/15 → …
Project: Research
-
The BIOCOAG project : Biological assessment of the control of anticoagulation
Douxfils, J. (PI), Mullier, F. (CoI), Dogné, J.-M. (CoI), Siriez, R. (Researcher), Evrard, J. (Researcher) & Vassart, J. (Researcher)
1/09/11 → …
Project: Research
-
The MAS project : Measure And See the activity of direct oral anticoagulant in the clinical context
Douxfils, J. (Researcher) & Mullier, F. (CoI)
Project: Research
-
Assessment of frailty in older patients before cardiac surgery
de SAINT HUBERT, M. (PI), Gourdin, M. (PI), Michaux, I. (PI), TOUSSAINT, O. (PI), Caron, N. (PI) & Mullier, F. (PI)
1/04/12 → 31/12/13
Project: Research
-
Techniques for measuring NETosis: A critical literature review and outlook for standardization
Gillot, C., Bouarroudj, H., Decarpentrie, J., Mullier, F., Dogné, J.-M. & Douxfils, J., 7 May 2026, (E-pub ahead of print) In: Thrombosis Research. 262, p. 109697Research output: Contribution to journal › Review article › peer-review
-
Thrombin generation and the pharmacodynamics of parenteral anticoagulants
Shaw, J. R., Maier, C. L., Hardy, M., Mullier, F., Douxfils, J., Tanaka, K., Rocca, B., Cate, H. T., Kim, P. Y., Carrier, M., Connors, J. M. & Levy, J. H., 10 Apr 2026, (E-pub ahead of print) In: Pharmacological reviews. 78, 3, p. 100135Research output: Contribution to journal › Review article › peer-review
-
Corrigendum to ‘Impact of asundexian on a panel of coagulation assays’(Research and Practice in Thrombosis and Haemostasis (2025) 9(5), (S2475037925002742), (10.1016/j.rpth.2025.102950))
Vassart, J., Ndzatou, D. B., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Demeure, F., Lebreton, A., Mullier, F., Favresse, J., Hardy, M., Dogné, J. M. & Douxfils, J., 2025, (Accepted/In press) In: Research and Practice in Thrombosis and Haemostasis. 103242.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro study
Hardy, M., Thonon, H., Douxfils, J., Vassart, J., Gouin–Thibault, I., Lessire, S., Lecompte, T. & Mullier, F., Oct 2025, In: Journal of Thrombosis and Haemostasis. 23, 10, p. 3173-3184 12 p.Research output: Contribution to journal › Article › peer-review
-
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting
Devis, L., Arachchillage, D. J., Hardy, M., Mansour, A., Catry, E., Closset, M., Gouin-Thibault, I., Frere, C., Lecompte, T., Alberio, L., Cadamuro, J., Lippi, G. & Mullier, F., 19 Feb 2025, In: Hämostaseologie. 45, 1, p. 24-48 25 p.Research output: Contribution to journal › Review article › peer-review
Open Access
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
-
Clustering and kernel density estimation for assessment of measurable residual disease by flow cytometry
Jacqmin, H. (Contributor), Chatelain, B. (Contributor), Louveaux, Q. (Contributor), Jacqmin, P. (Contributor), Dogné, J.-M. (Contributor), Graux, C. (Contributor) & Mullier, F. (Contributor), Zenodo, 18 May 2020
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 6 Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
Thesis
-
Quantification and characterization of microvesicles: applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer
Mullier, F. (Author), Dogne, J.-M. (Supervisor), Masereel, B. (President), Chatelain, B. (Co-Supervisor), Michiels, C. (Jury), Latinne, D. (Jury), Chatelain, C. (Jury), Wallemacq, P. (Jury), Harrison, P. A. (Jury) & Hoylaerts, M. F. (Jury), 26 Mar 2012Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Press/Media
-
New Findings from University of Namur in the Area of Science Described (Techniques for measuring NETosis: A critical literature review and outlook for standardization)
Dogné, J.-M., Douxfils, J., Mullier, F. & Gillot, C.
21/05/26
1 item of Media coverage
Press/Media: Expert Comment
-
Researchers from University of Namur Detail Findings in Thrombosis and Haemostasis (Impact of asundexian on a panel of coagulation assays)
Dogné, J.-M., Douxfils, J., Mullier, F., Morimont, L., Didembourg, M. & Favresse, J.
11/08/25
1 item of Media coverage
Press/Media: Expert Comment
-
Catholic University Louvain (UCLouvain) Reports Findings in Sustainability Research (Revisiting the Environmental Impact of Inappropriate Clinical Laboratory Testing: A Comprehensive Overview of Sustainability, Economic, and Quality of Care ...)
Mullier, F., Closset, M., Catry, E. & Degosserie, J.
10/10/24
1 item of Media coverage
Press/Media: Expert Comment
-
Study Results from University of Namur Broaden Understanding of Coxsackievirus (Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome)
Dogné, J.-M., Douxfils, J., Mullier, F., Favresse, J. & Gillot, C.
10/01/23
1 item of Media coverage
Press/Media: Expert Comment
-
New Thrombosis Study Findings Recently Were Published by Researchers at Catholic University of Louvain (UCLouvain) (Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system)
28/12/22
1 item of Media coverage
Press/Media: Expert Comment